Clinical Trials Browser

Phase 1 × INDUSTRY × emvododstat × Clear all

NCT03761069 2022-02-02

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myeloid, Acute

NCT00704821 2019-05-10

PTC299 for Treatment of Advanced Cancer

Phase 1 Terminated

Neoplasms

NCT00508586 2016-03-03

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms